CNMD - CONMED Corporation
| Previous Close | 81.89 |
| Open | 81.30 |
| Bid | 77.66 x 1200 |
| Ask | 86.10 x 800 |
| Day's Range | 80.23 - 81.93 |
| 52 Week Range | 56.91 - 85.91 |
| Volume | 117,638 |
| Avg. Volume | 301,933 |
| Market Cap | 2.268B |
| Beta (3Y Monthly) | 0.72 |
| PE Ratio (TTM) | 74.37 |
| EPS (TTM) | 1.08 |
| Earnings Date | Jul 30, 2019 - Aug 5, 2019 |
| Forward Dividend & Yield | 0.80 (1.00%) |
| Ex-Dividend Date | 2019-03-14 |
| 1y Target Est | 89.40 |
- Zacks•2 days ago
QIAGEN Partners Inovio to Develop Companion Diagnostics
QIAGEN's (QGEN) Sample to Insight workflows and expertise in developing diagnostic solutions will aptly compliment Inovio regarding Precision Medicine in immuno-oncology.
- Zacks•2 days ago
Thermo Fisher Acquires GlaxoSmithKline's Drug Production Site
The latest acquisition aligns with Thermo Fisher's (TMO) strategy of enhancing capabilities of its Pharma Services through the right balance of capital investment, and merger and acquisition.
- Zacks•2 days ago
Here's Why You Should Hold on to Tandem (TNDM) Stock for Now
Investor confidence in Tandem Diabetes (TNDM) is still high on several positive factors.
- Zacks•2 days ago
Varian Medical Installs ProBeam at Research Hub in Singapore
Varian Medical's (VAR) APAC revenues grow 7% year over year in the fiscal second quarter.
- Zacks•4 days ago
Integra LifeSciences Rides on Product Launch, Faces Rivalry
Benefiting from new products and an improved sales force performance, Integra LifeSciences (IART) projects speedy organic growth in the second half of 2019.
- Zacks•5 days ago
STERIS (STE) Q4 Earnings Surpass Estimates, Margins Rise
STERIS (STE) witnesses solid revenue growth across each of its operating segments in the reported quarter.
- Zacks•5 days ago
Medtronic to Acquire Titan Spine for Spine Portfolio Boost
According to Medtronic (MDT), interbody implants material and shape play a vital role in the bone growth process during fusions and presently, titanium interbody devices are rapidly becoming popular.
- Zacks•5 days ago
ABIOMED's Impella 5.0 and LD Receive Expanded FDA Approvals
ABIOMED's (ABMD) FDA-approved Impella 2.5 and Impella CP treat certain advanced heart failure patients.
- Zacks•6 days ago
Abbott Rides on Strong CGM, Poor Rhythm Management Ails
Abbott (ABT) is attracting constant attention with developments in its flagship, sensor-based continuous glucose monitoring (CGM) system called FreeStyle Libre System.
- Simply Wall St.•6 days ago
Should We Worry About CONMED Corporation's (NASDAQ:CNMD) P/E Ratio?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- Zacks•6 days ago
Medtronic's (MDT) EV ICD Pilot Study Results Encourage
The study highlights the benefits of traditional, transvenous ICDs offered by the Medtronic's (MDT) EV ICD system.
- Zacks•6 days ago
Nevro (NVRO) Q1 Loss Wider Than Expected, Revenues Down Y/Y
Nevro's (NVRO) domestic and international revenues fall year over year in Q1.
- Zacks•6 days ago
Here's Why You Should Invest in Illumina (ILMN) Stock Now
Illumina (ILMN) has been gaining investor confidence on robust performance.
- Zacks•9 days ago
National Vision's (EYE) Q1 Earnings Beat, Margins Decline
National Vision's (EYE) consistent strength in comps is owing to higher customer transaction for the past 69 straight quarters.
- Zacks•9 days ago
Syneos' (SYNH) Q1 Earnings Miss Estimates, Revenues In Line
Syneos Health (SYNH) sees strong year-over-year revenue growth across both operating segments ??? Clinical Solutions and Commercial Solutions.
- Zacks•9 days ago
LHC Group (LHCG) Earnings Beat, Revenues Miss Estimates in Q1
LHC Group (LHCG) gains from solid home health services in Q1, raises 2019 view.
- Zacks•10 days ago
BioScrip's Option Care Merger on Track, Q1 Loss Narrows
BioScrip (BIOS) is highly upbeat about the strategic and financial virtues of Option Care consolidation.
- Zacks•10 days ago
Cardinal Health (CAH) Q3 Earnings Top Estimates, Revenues Lag
Cardinal Health (CAH) Q3 results benefit from strong performance by Pharmaceutical segment and higher revenues. However, sluggishness in the Medical segment remains a concern.
- Zacks•10 days ago
Bio-Rad (BIO) Q1 Earnings Beat Estimates, Margins Expand
Bio-Rad (BIO) witnesses revenue growth at the Life Sciences segment in Q1 on strength in cell biology, droplet Digital PCR and other product lines.
- Zacks•10 days ago
Wright Medical (WMGI) Q1 Earnings & Revenues Top Estimates
Wright Medical (WMGI) Q1 results benefit from higher revenues, solid show by Lower as well as Upper Extremities segments and gross margin expansion. However, rising costs remain a woe.
- Zacks•10 days ago
OPKO Health (OPK) Reports Loss in Q1, Misses Revenue Estimates
Lower revenues, weak performing product segment and contraction in gross margin impact OPKO Health's (OPK) Q1 results.
- Zacks•10 days ago
Becton, Dickinson (BDX) Q2 Earnings Beat, Revenues Fall Y/Y
Becton, Dickinson (BDX) gains from BD Medical in fiscal Q2; international revenues down.
- Zacks•10 days ago
Phibro's (PAHC) Q3 Earnings Miss Estimates, Margins Fall
Phibro Animal Health (PAHC) sees year-over-year revenue decline in two core segments ??? Animal Health and Mineral Nutrition.
- Zacks•11 days ago
Haemonetics (HAE) Q4 Earnings Top Mark, Operating Margin Up
A steady momentum in new business wins and consistent geographical expansion drive Haemonetics' (HAE) top-line results
- Zacks•11 days ago
Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat
Bruker's (BRKR) current focus on product development through higher R&D investment stokes investors' positive sentiment around the stock.
